Amgen (AMGN) Announces Japanese Approval of Repatha as PCSK9 Inhibitor
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE